Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-593.13%
operating margin TTM
-654.25%
revenue TTM
466.38 Million
revenue per share TTM
4.67$
valuation ratios | |
|---|---|
| pe ratio | -5.63 |
| peg ratio | 0.03 |
| price to book ratio | 2.89 |
| price to sales ratio | 40.25 |
| enterprise value multiple | -6.97 |
| price fair value | 2.89 |
profitability ratios | |
|---|---|
| gross profit margin | 74.05% |
| operating profit margin | -654.25% |
| pretax profit margin | -593.06% |
| net profit margin | -593.13% |
| return on assets | -34.13% |
| return on equity | -45.77% |
| return on capital employed | -45.08% |
liquidity ratio | |
|---|---|
| current ratio | 4.82 |
| quick ratio | 4.82 |
| cash ratio | 1.55 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 85.72 |
| cash conversion cycle | -85.72 |
| receivables turnover | 0.00 |
| payables turnover | 4.26 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.15 |
| debt equity ratio | 0.22 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.18 |
| interest coverage | -29.29 |
| cash flow to debt ratio | -2.15 |
cash flow ratios | |
|---|---|
| free cash flow per share | -4.30 |
| cash per share | 10.27 |
| operating cash flow per share | -4.19 |
| free cash flow operating cash flow ratio | 1.03 |
| cash flow coverage ratios | -2.15 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -38.82 |
Frequently Asked Questions
When was the last time Beam Therapeutics Inc. (NASDAQ:BEAM) reported earnings?
Beam Therapeutics Inc. (BEAM) published its most recent earnings results on 05-11-2024.
What is Beam Therapeutics Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Beam Therapeutics Inc. (NASDAQ:BEAM)'s trailing twelve months ROE is -45.77%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Beam Therapeutics Inc. (BEAM) currently has a ROA of -34.13%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did BEAM's net profit margin stand at?
BEAM reported a profit margin of -593.13% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is BEAM's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.82 in the most recent quarter. The quick ratio stood at 4.82, with a Debt/Eq ratio of 0.22.